e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials
Stefano Barco, Eric Vicaut, Frederikus A. Klok, Mareike Lankeit, Guy Meyer, Stavros V. Konstantinides
Source:
Eur Respir J, 51 (1) 1701775; 10.1183/13993003.01775-2017
Journal Issue:
January
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stefano Barco, Eric Vicaut, Frederikus A. Klok, Mareike Lankeit, Guy Meyer, Stavros V. Konstantinides. Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials. Eur Respir J, 51 (1) 1701775; 10.1183/13993003.01775-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Should thrombolysis and sildenafil be given in the acute management of patients with large pulmonary embolism? An assessment of the short and long-term outcomes.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Advances in the clinical prediction rules that are used to assess patients with possible pulmonary embolism
Source: International Congress 2018 – Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism
Year: 2018
Adequate use of pulmonary embolism clinical prediction rule in COPD patients
Source: Eur Respir J 2011; 37: 219-220
Year: 2011
Comparison of three clinical prediction rules among patients with suspected pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 685s
Year: 2004
Have we found how to identify candidates for thrombolysis among normotensive patients with acute pulmonary embolism?
Source: Eur Respir J 2016; 47: 1054-1056
Year: 2016
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?
Source: Eur Respir J 2015; 46: 1551-1553
Year: 2015
Comparison of risk assessment strategies for not-high-risk pulmonary embolism
Source: Eur Respir J 2016; 47: 1170-1178
Year: 2016
Identification of intermediate-risk patients with acute symptomatic pulmonary embolism
Source: Eur Respir J 2014; 44: 694-703
Year: 2014
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017
A radiomics nomogram based on CT pulmonary angiographic data for predicting adverse outcomes in non-high-risk acute pulmonary embolism patients
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018
Management appropriateness and outcomes of patients with acute pulmonary embolism
Source: Eur Respir J, 51 (5) 1800445; 10.1183/13993003.00445-2018
Year: 2018
Clinical probability and d-dimer utility in the context of suspected pulmonary embolism: The safe approach
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Clinical characteristics and outcomes of patients with clinically unsuspected pulmonary embolism versus patients with clinically suspected pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Comparison of three clinical probability methods among patients with suspected pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Determinants and prognostic impact of diagnostic delay in pulmonary embolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018
The analysis of pulmonary tromboembolism (PTE) in structure of mortality of therapeutic and surgical patients
Source: Eur Respir J 2007; 30: Suppl. 51, 603s
Year: 2007
Early discharge of patients with pulmonary embolism: feasibility of domicillary anticoagulation
Source: Eur Respir J 2003; 22: Suppl. 45, 219s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept